Frequently Asked Questions
The market is segmented based on Global Next-Generation Biomanufacturing Market Segmentation, By Workflow and Product (Continuous Upstream Biomanufacturing, Single-Use Upstream Biomanufacturing, and Downstream Biomanufacturing), Application (Monoclonal Antibodies, Hormones, Vaccines, Recombinant Proteins, and Others), End User (Commercial Stage, and Preclinical and Development Stage) – Industry Trends and Forecast to 2031
.
The Global Next Generation Biomanufacturing Market size was valued at USD 24.23 USD Billion in 2023.
The Global Next Generation Biomanufacturing Market is projected to grow at a CAGR of 9.85% during the forecast period of 2024 to 2031.
The market report covers data from the U.S., Canada and Mexico in North America, Germany, France, U.K., Netherlands, Switzerland, Belgium, Russia, Italy, Spain, Turkey, Rest of Europe in Europe, China, Japan, India, South Korea, Singapore, Malaysia, Australia, Thailand, Indonesia, Philippines, Rest of Asia-Pacific (APAC) in the Asia-Pacific (APAC), Saudi Arabia, U.A.E., South Africa, Egypt, Israel, Rest of Middle East and Africa (MEA) as a part of Middle East and Africa (MEA), Brazil, Argentina and Rest of South America as part of South America..
